A meta‐analysis of toxicities related to hydroxycarbamide dosing strategies

Joacy G. Mathias(Duke University), Jeremie H. Estepp(St. Jude Children's Research Hospital), Jane S. Hankins(St. Jude Children's Research Hospital), Kristen E. Howell(Texas A&M University), Winfred C. Wang(St. Jude Children's Research Hospital), Val Nolan(St. Jude Children's Research Hospital), Meghan M. Taylor(University of Memphis), James G. Gurney(Hydro One (Canada))
eJHaem
April 26, 2020
10.1002/jha2.7
Cited by 3

Related Papers

Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer
|JAMA|2013|1.3k
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
|Blood|2007|536
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study
|Pediatric Blood & Cancer|2013|459
Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings
|Journal of Clinical Oncology|2009|418
Medical Care in Long-Term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
|Journal of Clinical Oncology|2008|418